About Dr. Chetan Kalal — Hepatologist & Liver Transplant Physician, Mumbai

Dr. Chetan Kalal is Maharashtra’s first DM Hepatologist — a milestone that marks a turning point in the state’s specialist liver care. A consultant Hepatologist and Liver Transplant Physician based in Mumbai, he currently practises at Gleneagles Hospital. He trained under the direct mentorship of Prof. Shiv Kumar Sarin at the Institute of Liver and Biliary Sciences (ILBS), New Delhi — one of the world’s foremost authorities on liver disease.

Qualifications & Training

Dr. Kalal completed his DM in Hepatology from the Institute of Liver and Biliary Sciences (ILBS), New Delhi in 2016, training under the direct mentorship of Prof. Shiv Kumar Sarin — one of the world’s foremost authorities on liver disease.

Recent Academic Activity

2026 — Conferences & Invited Talks

• Post-EASL Congress Indian Webinar — International-National KOL Panel: Hepatology. Aug–Sep 2026. Invited Panelist.
• Bengal Liver Summit 2026 — Invited Faculty.
• DRILLS 2026 — Invited Faculty (Decisions Reasoning Innovations & Learning in Liver DiseaseS, 7th Edition) — ILBS, Pullman Aerocity, New Delhi. 13–14 June 2026.
• LTSICON 2026 Midterm — Invited Faculty, Case-Based Panel: Viral and Invasive Fungal Infection — Cause and Effect Relationship with Graft Dysfunction — Liver Transplant Society of India Conference, Conrad Pune. 20–21 June 2026. Read full topic overview →
• Organising Secretary, Grand Rounds in Hepatology 2026 — INASL Mid-Term Meeting, The St. Regis Mumbai, 1–3 May 2026. Theme: Clinical Dilemmas in Day-to-Day Hepatology Practice. Conference overview →
• Obesity Masterclass 2026 — Invited Faculty: GLP-1 Receptor Agonists in MASH and Metabolic Liver Disease. Read more →
• IMPA 2026 — Invited Faculty: Weight Loss and Beyond — The Comprehensive Benefits of Treating MASH. Read more →
• GLTS 2026 — Invited Faculty, Gleneagles Liver and Transplant Summit, ITC Grand Chola, Chennai. 9–12 April 2026.
• LIVERCON 2026 — Invited Faculty — National Hepatology Conference, Taj Lands End, Mumbai. 4–5 April 2026.
• CRITICON 2026 — Invited Faculty — National Critical Care Conference.
• Zydus Life Sciences CME — Speaker & Moderator: “Decoding the Obesity–Liver Continuum.” April 2026.
• Juhu IMA 2026 — Invited Faculty: Role of Nutritional Therapy in Alcoholic Hepatitis. Read more →
• IMA Mumbai West — Faculty Speaker, Medicine Update. 24 February 2026.
• BUILD 4.0 — Invited Faculty, Brainstorming & Updates on Innovations in Liver Diseases, 4th Edition, Mumbai. 6–8 February 2026.

2025 — Conferences & Invited Talks

• LTSICON 2025 — Invited Faculty — 8th Annual Conference of the Liver Transplantation Society of India.
• Grand Rounds in Hepatology 2025 — Invited Faculty Speaker — Gleneagles Hospital, Mumbai. October 2025.
• Obesity Masterclass 2025 (Eli Lilly) — Invited Speaker — Navi Mumbai. December 2025.
• MAHAISGCON 2025 — Invited Faculty — Maharashtra State Chapter Conference, Indian Society of Gastroenterology, Thane. September 2025.
• Ujjwal 2025 — Invited Faculty — Indian Dietetic Association (RD Board). December 2025.
• APASL AARC Consensus Meeting — Faculty Investigator — APASL STC Conference, Yangon, Myanmar. December 2025.

Advisory Panels & Expert Roles

• Advisory Panel — Novo Nordisk (GLP-1 Receptor Agonists in Metabolic Liver Disease & Obesity)
• Advisory Panel — Eli Lilly (GLP-1/GIP Dual Agonists: Tirzepatide in MASH & Obesity)

Awards & Recognition

• AASLD Foundation Young Investigator Travel Award — The Liver Meeting®, Boston, MA, November 11–15, 2016. Presented by the American Association for the Study of Liver Diseases (AASLD) to young investigators submitting outstanding research. [Verified source]
• AASLD Foundation Young Investigator Travel Award 2017 (American Association for the Study of Liver Diseases)
• Dr. A P J Abdul Kalam Health Award 2024 — Excellence in Hepatology (Liver Care) and Community Health. Conferred by Nandish Communication on Doctor’s Day (July 1, 2024). [TheHealthSite.com]
• Fellow, National Academy of Medical Sciences — FNAMS (2022–23)
• First DM Hepatologist of Maharashtra

Clinical Expertise

• Acute-on-Chronic Liver Failure (ACLF)
• Acute Liver Failure
• Liver Transplantation (evaluation, pre- and post-transplant care)
• Viral Hepatitis — Hepatitis B, Hepatitis C, Hepatitis D
• Cirrhosis and its complications
• Alcoholic and Non-Alcoholic Fatty Liver Disease (NAFLD/MASLD)
• Drug-Induced and Herb-Induced Liver Injury (DILI/HILI)
• Portal Hypertension
• Nutrition and Sarcopenia in Liver Disease
• Endoscopy: Upper GI, Colonoscopy, Liver Biopsy, FibroScan

Research

• ACLF — contributing to APASL AARC criteria development and validation
• Acute Liver Failure — principal investigator, MAHAL (Management of Acute Hepatic fAiLure) RCT
• Nutrition and Sarcopenia in Cirrhosis
• Viral Hepatitis — epidemiology and treatment outcomes
• DILI/HILI — drug and herb-induced liver injury in the Indian population
• MASLD/Metabolic Liver Disease

Dr. Kalal has 26 publications indexed on PubMed. View his work on PubMed and Google Scholar · PubMed Profile · ORCID.

Where to Consult

Current: Gleneagles Hospital Mumbai, Maharashtra, India

Previous: Sir H.N. Reliance Foundation Hospital, Raja Rammohan Roy Rd, Gleneagles Hospital, Vikhroli West, Mumbai, Girgaon, South Mumbai 400004 | Nanavati Max Super Speciality Hospital, Mumbai

Scholarly Identity and Research Profiles

Dr. Chetan Kalal’s research work is indexed across multiple global academic databases. Verified scholarly profiles:

• ORCID iD: https://orcid.org/0000-0002-5284-7890 — Unique researcher identifier linking all published work.
• PubMed / NCBI: PubMed author search — Kalal Chetan — 26 peer-reviewed publications indexed.
• Google Scholar: Google Scholar — Chetan Kalal Hepatology
• Frontiers Loop Profile: loop.frontiersin.org/people/1454916

Media & Press Coverage

• Hindustan Times — Can drinking black coffee daily reduce fatty liver risk? Hepatologist explains how much to drink and what to avoid — June 6, 2026. Dr. Kalal explains the protective role of coffee antioxidants (chlorogenic acid, caffeine) against liver inflammation, fibrosis progression, and MASLD risk — and why coffee alone cannot replace lifestyle change.

International Consultations and Second Opinions

Dr. Kalal accepts teleconsultation requests and written second opinions from patients and referring physicians worldwide — including from the United Kingdom, United States, Canada, Australia, New Zealand, UAE, Gulf (GCC) countries, Singapore, East Africa, and South Africa.

NRI patients and international patients seeking expert hepatology input for liver transplant evaluation, ACLF management, chronic hepatitis, or cirrhosis are encouraged to send medical records via the contact form for a structured expert review.

Common international referrals handled by Dr. Kalal:

• Liver transplant evaluation for patients in Dubai, Abu Dhabi, and across the UAE
• Second opinion on ACLF or acute liver failure for patients in the UK and USA
• Hepatitis B and C treatment guidance for NRI patients in Canada and Australia
• Liver disease management for patients in Kenya, South Africa, and East Africa
• Pre-transplant and post-transplant follow-up teleconsultation for patients in London, New York, Toronto, and Sydney

Mumbai is a 3-hour flight from Dubai, 9 hours from London, and 10 hours from Sydney — making Gleneagles Hospital Mumbai an accessible centre for international patients requiring in-person evaluation or liver transplantation at world-class quality and a fraction of Western costs.